Swelife supports collaboration within academia, industry and healthcare, with the goal to strengthen Life Science in Sweden and to improve public health. It is a strategic innovation programme, funded by the Swedish Government via the Swedish innovation agency, Vinnova, and by the programme’s partners. Swelife is a facilitator. Through a long-term, national perspective our work aims to contribute to these effects:
The knowledge and resources within life science in Sweden are utilised nationally through collaboration and coordination
Sweden offers good conditions for sustainable growth and international competitiveness in the life science sector
Citizens of Sweden have access to innovative, equal, and people-centred care
Life science in Sweden has a leading role in developments towards world-class health and sustainable growth.
Swelife facilitates and accelerates innovation and collaboration within life science – from ideas to benefits for society.
Budget and Support
More than 100 organisations from healthcare, academia and industry in Sweden currently support Swelife.
Swelife was established in the summer of 2014 when the Diabetes Agenda and SILS (Sweden as an International Centre for Life Science) jointly applied to launch a so-called strategic innovation area (SIO). The idea was to gather the Life Science regions in Sweden under one common national research and innovation agenda. The SIO on non-communicable diseases was approved in May 2014, changed its name to Swelife in the autumn, and in January 2015 included an additional agenda (PMC – Personalised Medicine Cancer).